CJC-1295 is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH) with tetrasubstituted modifications (D-Ala, Gln, Ala, Leu) that protect the peptide from degradation by the enzy
(19) This specificity is thought to arise from the higher expression of growth hormone receptors in visceral adipocytes compared to subcutaneous ones
If there is sufficient glutathione in the cell, the newly unstable oxidized glutathione pairs with available glutathione with the help of an enzyme called glutathione reductase
The synergistic effects of TB500 and BPC-157 can accelerate tissue repair, reduce inflammation, and support overall healing processes
The company has WHO-GMP, USFDA, and ISO certifications
Gastric pentadecapeptide for tissue repair and cytoprotection research